Nicole Gormley

Irreconcilable Differences: The Divorce Between Response Rates, Progression-Free Survival, and Overall Survival

Margret Merino, Yvette L. Kasamon, Marc R. Theoret et al. · Journal of Clinical Oncology · 2023 · 116 citations · Full text

Family Medicine, Progression-free Survival, Intimate Relationship +7

The saga of PI3K inhibitors in haematological malignancies: survival is the ultimate safety endpoint

Nicholas C. Richardson, Yvette L. Kasamon, Richard Pazdur et al. · The Lancet Oncology · 2022 · 95 citations

Pi3k Inhibitors, Oncology, Medicine +9

In Vivo Transfer of Intracellular Labels from Locally Implanted Bone Marrow Stromal Cells to Resident Tissue Macrophages

Edyta Pawelczyk, Elaine Jordan, Arun Balakumaran et al. · PLoS ONE · 2009 · 90 citations · Full text

Cell Therapy, Engineering, Harvested Plaques +16

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

Kenneth C. Anderson, Daniel Auclair, Gary J. Kelloff et al. · Clinical Cancer Research · 2017 · 87 citations

FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy

Vishal Bhatnagar, Nicole Gormley, Lola Luo et al. · The Oncologist · 2017 · 77 citations · Full text